Contacts could dispense drugs. (Drug Delivery).Eye medication usually comes in drops. That's not good, says Anuj Chauhan. Only about 5 percent of the medicine treats the eye. The rest drains into the body, where it can reach the bloodstream and cause complications. Better, Chauhan says, would be a more controlled way of getting medicines into the eye. That's why he and his coworkers at the University of Florida University of Florida is the third-largest university in the United States, with 50,912 students (as of Fall 2006) and has the eighth-largest budget (nearly $1.9 billion per year). UF is home to 16 colleges and more than 150 research centers and institutes. in Gainesville have created contact lens materials designed to continuously dispense drugs. To make sample lenses, the researchers first prepared 50-nanometer-wide spheres containing the anesthetic lidocaine lidocaine /li·do·caine/ (li´do-kan) an anesthetic with sedative, analgesic, and cardiac depressant properties, applied topically in the form of the base or hydrochloride salt as a local anesthetic; also used in the latter form as a . They added these nanoparticles to a common contact lens polymer called poly-2-hydroxyethyl methacrylate methacrylate /meth·ac·ry·late/ (meth-ak´ri-lat) an ester of methacrylic acid, or the resin derived from polymerization of the ester. See also acrylic resins, under resin. . The team made test lenses that were a little bigger and thicker than normal contacts. Despite the nanoparticles, the lenses retained their transparency. When placed in a beaker beaker /beak·er/ (bek´er) a glass cup, usually with a lip for pouring, used by chemists and pharmacists. beaker a round laboratory vessel of various materials, usually with parallel sides and often with a pouring spout. of water, the lenses leached their loads of anesthetic for 8 to 10 days. The researchers now plan to test their particles with timolol timolol /ti·mo·lol/ (ti´mo-lol) a nonselective beta-adrenergic blocking agent used as the maleate salt in the treatment of hypertension, the treatment and prophylaxis of recurrent myocardial infarction and the prophylaxis of migraine; , a glaucoma drug usually delivered in eye drops, and the antibiotic ciprofloxacin. They also hope to tune the lens material so it releases drug molecules uniformly over time. If all goes well, drug-releasing contacts may be on the market in about a decade, Chauhan says.--J.G. |
|
||||||||||||||||||||

Printer friendly
Cite/link
Email
Feedback
Reader Opinion